Myelin and oligodendrocyte lineage cell dysfunctions: New players in the etiology and treatment of depression and stress‐related disorders

E Boda - European Journal of Neuroscience, 2021 - Wiley Online Library
Depressive disorders are complex, multifactorial disorders that have been traditionally
attributed exclusively to neuronal abnormalities. However, recent studies have increased …

At baseline patients treated with esketamine have higher burden of disease than other patients with treatment resistant depression: learnings from a population based …

MS Cepeda, DM Kern, CM Canuso - Depression and anxiety, 2021 - Wiley Online Library
Introduction It is critical to assess who is being treated with a new marketed drug like
esketamine to understand how it is used in the real‐world setting and the effects of the …

Treatment resistant depression

SR Vaccarino, SH Kennedy - Ketamine for Treatment-Resistant Depression, 2021 - Elsevier
Approximately 50% of patients with major depressive disorder do not respond to their first
antidepressant treatment. With more antidepressant treatment trials, an individual's …

[PDF][PDF] prepublication copy

A Høstmælingen, P Ulvenes, HA Nissen-Lie, M Eielsen… - 2021 - researchgate.net
Objective: Depression is typically seen as composed of several factors (ie, cognitive,
affective, somatic) which may be targeted by different interventions (ie, pharmacotherapy …

[PDF][PDF] Meta-analysis of Salt Valproate Prevent Switch Associated with Antidepressants in Chinese Depressive Patients

D Shen, W Lv, F Sun, J Weidong - 2021 - scholar.archive.org
Objective: to study the e cacy of valproate in preventing switch rate related to antidepressant
in depressive patients. Methods: The related literature were searched in Chinese …